Elixirgen Scientific, Inc. is pleased to announce the opening of a new Japanese office located in Kawasaki city, Kanagawa Prefecture. The Japan office will allow Elixirgen Scientific to support a growing demand for induced pluripotent stem cell (iPSC) differentiation technologies in Japan and throughout the Asia/Pacific region. This is an important milestone as it is the […]
Elixirgen Scientific will be at the Society of Toxicology 59th Annual Meeting and ToxExpo in Anaheim, California. We will be exhibiting March 16-18th, so visit us at Booth #329 to learn more about how you can use our differentiated human iPS cells and differentiation kits to accelerate your research.
We hope you’ll join us at SLAS 2020 in San Diego, California. Visit us at Booth #1346 to learn more about how you can use our differentiated human iPS cells and differentiation kits for your high-throughput experiments, such as drug discovery and toxicity screening. All SLAS attendees who stop by our booth will receive an exclusive offer, so don’t miss out!
The Axion BioSystems Maestro and MED64 Presto multielectrode array (MEA) platforms enable label-free measurement of electrical activity of single cells or cellular networks. A key advantage of these MEA platforms is that cell excitability can be tracked in real-time and over the course of hours, weeks, or months using the same population of cells. Our […]
TOKYO, June 19, 2019 /PRNewswire/ — Ricoh Company, Ltd., (Tokyo, Japan) today announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc., (Baltimore, Maryland, USA), to develop innovative biomedical products and services that support drug discovery based on cell differentiation technology.